Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Affectis Pharmaceuticals
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 15 Aug, 2024
"update entity type supersets"
Golden AI
edited on 15 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
"Created via: prospector:3927:4120791"
Ivo Devereux
created this topic on 15 Aug, 2024
Edits made to:
Infobox
(
+14
properties)
Description
(
+86
characters)
Affectis Pharmaceuticals
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
Infobox
Is a
Company
Industry
Pharmaceutical industry
Biotechnology
Official Website
https://affectis.com
B2X
B2C
Number of Employees (Ranges)
11 – 50
Investors
Aescap Venture
EMBL Ventures
Founded Date
2002
Total Funding Amount (USD)
21,000,000
Latest Funding Round Date
March 22, 2010
Country
Germany
Headquarters
Dortmund
Latest Funding Round Amount (USD)
350,000
Find more companies like Affectis Pharmaceuticals
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE